Changes in bone mineral density and body
β
Hang Lee; Katelyn McGovern; Joel S. Finkelstein; Matthew R. Smith
π
Article
π
2005
π
John Wiley and Sons
π
English
β 106 KB
π 1 views
## Abstract ## BACKGROUND Initial treatment with a gonadotropinβreleasing hormone (GnRH) agonist increases fat mass, decreases lean body mass, and decreases bone mineral density (BMD) in men with prostate carcinoma. To the authors' knowledge, little is known regarding either the longβterm effects